Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain June 24, 2025
- 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
- Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
- Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies February 19, 2025
- The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Top 10 Life Science and Healthcare Market Predictions for 2020
Highly effective cancer therapies. Handheld hematology analyzers. A new and untapped world market. Social media selling life science tools. Science and Medicine Group publications, including Kalorama Information, Strategic Directions International (SDi), Bioinformatics, and IMV have made various projections for the new year in imaging, diagnostics, biotechnology, and life science instrument and supplies that can help […]
Kalorama Presents at BIOMedevice San Jose
The point of care diagnostic testing market is over $22 billion, about 2/3rds of that is self-care and physician office based testing. Point of care testing offers significant benefits in time-to-results, time-to-treatment, diagnostic relevance to providers and even patient confidence. They tend to cost more than lab-based tests, but in an overall context of care […]
Decentralized Hematology Tests Driving Market
Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. Kalorama Information has covered hematology for decades in its report The Worldwide Market for In Vitro Diagnostic Tests https://kaloramainformation.com/product/the-world-market-for-in-vitro-diagnostic-tests-12th-edition/ The basis of hematology testing is the complete blood count […]
Same – Day NGS Cancer Testing, New Liquid Bx, DNA/RNA Combos Among Developments at AMP 2019
Molecular vendors met in Baltimore at the Association for Molecular Pathology meeting in Baltimore Wednesday for pre-convention corporate workshops and presentations. Not surprisingly, some news was made. Several vendors presented new solutions to chip away at result times. Thermo Fisher Scientific launched its Ion Torrent Genexus System, an integrated next-generation sequencing (NGS) platform featuring an […]
Major Molecular Diagnostic Vendors Announce Workshops for AMP
As molecular pathologists, pharmaceutical companies and in vitro diagnostic vendors gather in Baltimore MD for the upcoming Association for Molecular Pathology (AMP) in Baltimore, MD. corporate workshops have been announced. The workshops indicate the direction the industry is going, with new molecular technologies such as mass spec and NGS replacing traditional ones in some cases. Roche, Abbott […]
Molecular Diagnostics Market Now Larger Than the Economies of 50 Nations, per New Report
As molecular testing vendors meet this month in Baltimore for the Association for Molecular Pathology (AMP) 2019 meeting, market research firm Kalorama Information, specialist in in vitro diagnostics markets, estimates that tests aiding the detection and treatment of disease at the molecular level are the fastest-growing test category in all diagnostics. And the firm says […]
Kalorama, Science and Medicine Group Will Be at AMP 2019
Kalorama Information, along with representatives from parent company Science and Medicine Group, will be present at the Association for Molecular Pathology (AMP) meeting in Baltimore Maryland. We will be covering the meeting for Lab Pulse.com, Kalorama Information and Instrument Business Outlook. Seminars of particular interest to Kalorama Information: Practical Approaches to Centralizing (or Decentralizing) Molecular […]
IVD Procedures Reach 68 Billion
The global volume of in vitro diagnostic (IVD) procedures has reached over 68 billion and is forecast to increase 3.4% annually to 81.0 billion in 2024, according to Kalorama’s new report on procedure volumes. These statistics are important for business planning, particularly for new products. The same timeframe will see worldwide sales of IVD products […]
Qiagen/Illumina Deal: “positive development for clinical NGS”
This is a positive development for next-generation sequencing’s clinical future, not only in diagnostic assessment of disease but also in therapy selection. But this is still about future development, and we’ll watch the products that the collaboration produces. We’ll also watch what the competition does — partnerships oft beget other partnerships.” KALORAMA as quoted in […]
Six Trends You’ll Want to Know in the IVD Market
Kalorama has released its 12th Edition of The Worldwide Market for In Vitro Diagnostic Tests. It is a complete market study of the 69+ billion-dollar industry. Among the report’s findings are the following: Some Improvement in European IVD Markets: Kalorama found reversed austerity, LDT spending, and test innovation increased Europe market size, somewhat. As Europe is an important market, this boosted the IVD market as a whole. New […]